118 related articles for article (PubMed ID: 21481331)
1. [Gottron-like papules induced by sunitinib].
Martorell-Calatayud A; Sanmartín O; Traves-Zapata V; Guillén C
Actas Dermosifiliogr; 2011 Jun; 102(5):385-7. PubMed ID: 21481331
[No Abstract] [Full Text] [Related]
2. Scrotal cutaneous side effects of sunitinib.
Billemont B; Barete S; Rixe O
N Engl J Med; 2008 Aug; 359(9):975-6; discussion 976. PubMed ID: 18753659
[No Abstract] [Full Text] [Related]
3. Sunitinib-induced hand-foot syndrome: a new, distinct form.
Fife DJ; Wu JJ; Behnam SE; Linden KG
Clin Exp Dermatol; 2010 Mar; 35(2):200-1. PubMed ID: 19486049
[No Abstract] [Full Text] [Related]
4. Eruptive melanocytic nevi in a patient undergoing treatment with sunitinib.
Jiménez-Gallo D; Albarrán-Planelles C; Linares-Barrios M; Martínez-Rodríguez A; Báez-Perea JM
JAMA Dermatol; 2013 May; 149(5):624-6. PubMed ID: 23677103
[No Abstract] [Full Text] [Related]
5. Sunitinib-induced subungual splinter haemorrhage and acral erythema.
Nakamura M; Miyachi Y
Eur J Dermatol; 2008; 18(3):344-5. PubMed ID: 18474471
[No Abstract] [Full Text] [Related]
6. Gottron-like papules induced by hydroxyurea.
Yoshida K; Saito M; Amagai M; Ikeda Y
Clin Exp Dermatol; 2005 Mar; 30(2):191-2. PubMed ID: 15725256
[No Abstract] [Full Text] [Related]
7. Erosive nappy erythema following sunitinib intake.
Kharmoum S; Errihani H
Pan Afr Med J; 2013; 14():46. PubMed ID: 23560129
[No Abstract] [Full Text] [Related]
8. [Cutaneous side effects of sorafenib and sunitinib].
Autier J; Mateus C; Wechsler J; Spatz A; Robert C
Ann Dermatol Venereol; 2008 Feb; 135(2):148-53; quiz 147, 154. PubMed ID: 18342102
[No Abstract] [Full Text] [Related]
9. Palmar-plantar erythrodysesthesia secondary to sunitinib treatment resulting in necrotic foot syndrome aggravated by background diabetic vascular disease.
Guenova E; Weber HO; Voykov B; Metzler G; Mitev V; Berneburg M; Hoetzenecker W; Röcken M
Arch Dermatol; 2008 Aug; 144(8):1081-2. PubMed ID: 18711102
[No Abstract] [Full Text] [Related]
10. A case of pyoderma gangrenosum possibly associated with sunitinib treatment.
Ueharaguchi Y; Kabashima K; Sasahashi M; Matsuda A; Matubara K; Matsui M
Int J Dermatol; 2013 May; 52(5):634-6. PubMed ID: 23590380
[No Abstract] [Full Text] [Related]
11. Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.
Suwattee P; Chow S; Berg BC; Warshaw EM
Arch Dermatol; 2008 Jan; 144(1):123-5. PubMed ID: 18209189
[No Abstract] [Full Text] [Related]
12. Blackberry-induced hand-foot skin reaction to sunitinib.
Boone SL; Jameson G; Von Hoff D; Lacouture ME
Invest New Drugs; 2009 Aug; 27(4):389-90. PubMed ID: 18998055
[TBL] [Abstract][Full Text] [Related]
13. Sunitinib-induced pseudoporphyria.
Sanz-Motilva V; Martorell-Calatayud A; Llombart B; Requena C; Serra-Guillén C; Nagore E; Guillén C; Traves V; Sanmartín O
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1848-50. PubMed ID: 24813651
[No Abstract] [Full Text] [Related]
14. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK
Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553
[TBL] [Abstract][Full Text] [Related]
15. Sunitinib-induced scrotal cutaneous side-effect.
Chou CY; Wang KH; Lin YH; Lin YT; Tsai HH
J Dermatol; 2013 Jan; 40(1):67-8. PubMed ID: 23078345
[No Abstract] [Full Text] [Related]
16. Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib.
Lipworth AD; Robert C; Zhu AX
Oncology; 2009; 77(5):257-71. PubMed ID: 19923864
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy.
Lo JA; Fisher DE; Flaherty KT
JAMA Oncol; 2015 Dec; 1(9):1340-1. PubMed ID: 26270186
[No Abstract] [Full Text] [Related]
18. Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib.
McLellan B; Kerr H
Dermatol Ther; 2011; 24(4):396-400. PubMed ID: 21910797
[TBL] [Abstract][Full Text] [Related]
19. Disseminated maculopapular eruption caused by leuprorelin acetate.
Sugita K; Kabashima K; Tokura Y
Eur J Dermatol; 2008; 18(5):603-4. PubMed ID: 18779115
[No Abstract] [Full Text] [Related]
20. Papuloerythroderma of Ofuji induced by furosemide.
Sugita K; Kabashima K; Nakashima D; Tokura Y
J Am Acad Dermatol; 2008 Feb; 58(2 Suppl):S54-5. PubMed ID: 18191712
[No Abstract] [Full Text] [Related]
[Next] [New Search]
